EUDA Health Holdings Limited (NASDAQ:EUDA - Get Free Report) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 20,600 shares, a growth of 73.1% from the March 15th total of 11,900 shares. Currently, 0.1% of the company's stock are sold short. Based on an average daily volume of 105,100 shares, the days-to-cover ratio is presently 0.2 days.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in EUDA Health stock. XTX Topco Ltd acquired a new position in EUDA Health Holdings Limited (NASDAQ:EUDA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,463 shares of the company's stock, valued at approximately $75,000. XTX Topco Ltd owned about 0.07% of EUDA Health as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 4.35% of the company's stock.
EUDA Health Trading Down 2.8 %
Shares of NASDAQ EUDA traded down $0.11 during mid-day trading on Tuesday, reaching $3.86. The company had a trading volume of 130,324 shares, compared to its average volume of 76,662. EUDA Health has a twelve month low of $1.75 and a twelve month high of $6.30. The stock's 50 day moving average is $3.83 and its 200-day moving average is $4.13.
Analyst Ratings Changes
Separately, Greenridge Global raised shares of EUDA Health to a "strong-buy" rating in a research report on Monday, December 23rd.
Check Out Our Latest Stock Analysis on EUDA
About EUDA Health
(
Get Free Report)
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.
Further Reading
Before you consider EUDA Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUDA Health wasn't on the list.
While EUDA Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
